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Posterior polymorphous corneal dystrophy (PPCD) is a dominantly inherited disorder of the corneal
endothelium that has been associated with mutations in the zinc-ﬁnger E-box binding homeobox 1 gene
(ZEB1) gene in approximately one-third of affected families. While the corneal dystrophies have tradi-
tionally been considered isolated disorders of the corneal endothelium, we have recently identiﬁed
two cases of maldevelopment of the corpus callosum in unrelated individuals with PPCD.
The proband of the ﬁrst family was diagnosed shortly after birth with agenesis of the corpus callosum
and several other developmental abnormalities. Karyotype, FISH and whole genome copy number variant
analyses were normal. She was subsequently diagnosed with PPCD, prompting screening of the ZEB1
gene, which identiﬁed a novel deletion (c.449delG; p.(Gly150Alafs36)) present in the heterozygous state
that was not identiﬁed in either unaffected parent. The proband of the second family was diagnosed sev-
eral months after birth with thinning of the corpus callosum and PPCD. Whole genome copy number var-
iant analysis revealed a 1.79 Mb duplication of 17q12 in the proband and her father and brother, neither
of whom had PPCD. ZEB1 sequencing identiﬁed a novel deletion (c.1913-1914delCA; p.(Ser638Cysfs5))
present in the heterozygous state, which was also identiﬁed in the proband’s affected mother. Thus,
we report the ﬁrst two cases of the association of PPCD with a developmental abnormality of the brain,
in this case maldevelopment of the corpus callosum.
 2014 Elsevier B.V. All rights reserved.1. Introduction
Agenesis of the corpus callosum (ACC), describes the complete
or partial absence of the sheet of nerve ﬁber bundles derived from
neural crest tissue that connect the right and left hemispheres of
the brain, and is estimated to occur in approximately 1 in 4000–
5000 individuals in the general population (Paul et al., 2007).
Abnormal development of the corpus callosum (CC) is accompa-
nied by variable degrees of cognitive dysfunction, such as problem
solving skills, that parallel the severity of aberrant corpus callosum
development (Paul et al., 2007). Investigations into the genetic
cause of ACC have demonstrated evidence of linkage to 12 genomic
loci (O’Driscoll et al., 2010). ACC typically is associated with an
autosomal recessive or an X-linked recessive inheritance, although
autosomal dominant inheritance has been reported (Inbar et al.,
1997). While a variety of ocular abnormalities have been previ-
ously associated with various syndromes that arise from an abnor-mally developed CC, such as Aicardi syndrome, Septo-optic
Dysplasia, Mowat–Wilson Syndrome, and Menkes Syndrome, none
have previously included an inherited disorder of the cornea (Ariss
et al., 2012; Ferreira et al., 1998; Fruhman et al., 2012; Goyal,
Watts, & Hourihan, 2010; Masri et al., 2011).
Posterior polymorphous corneal dystrophy (PPCD) is a domi-
nantly inherited disorder of the neural crest-derived corneal endo-
thelium that is associated with characteristic corneal endothelial
morphologic abnormalities (Shimizu et al., 2004). While corneal
dystrophies are typically considered isolated disorders of the cor-
nea without associated ocular or extraocular manifestations, PPCD
has been associated with a variety of other ocular and nonocular
disorders, including keratoconus, non-keratometric corneal steep-
ening, Alport syndrome, inguinal hernia and hydrocele formation
(Aldave et al., 2007; Cremona et al., 2009; Krafchak et al., 2005;
Raber et al., 2011; Teekhasaenee et al., 1991). In approximately
1/3 of affected probands screened to date, mutations have been
identiﬁed in the zinc-ﬁnger E-box binding homeobox 1 gene
(ZEB1) gene, which is the genetic feature that deﬁnes PPCD3
(Aldave et al., 2007; Bakhtiari et al., 2013; Krafchak et al., 2005;
Lechner et al., 2013; Liskova et al., 2007, 2013; Nguyen et al.,
2010; Vincent et al., 2009). ZEB1 is a transcription factor that has
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neal dystrophy (Mehta et al., 2008; Riazuddin et al., 2010). ZEB1
also plays a signiﬁcant role in the development of the neural tube
and its derivatives, as an absence of ZEB1 gene expression is asso-
ciated with severe defects in neurodevelopment, such as exen-
cephaly and a failure of neural tube closure in a mouse model
(Liu et al., 2008). ZEB1 is also expressed in cerebral progenitor cells,
regions of the lateral ventricles and other areas of the brain (Liu
et al., 2008), indicating that ZEB1 may play a role in cell differenti-
ation and regional brain development. We report one such devel-
opmental anomaly, agenesis and hypoplasia of the corpus
callosum, in two individuals with PPCD3.
2. Materials and methods
Study approval was obtained from the Institutional Review
Board at the University of California, Los Angeles (UCLA IRB #
94-07-243-(33A and 34)).
2.1. Patient identiﬁcation/DNA collection and preparation
A slit lamp examination was performed of the proband of each
family and available family members to determine their affected
status. The diagnosis of PPCD was based upon the presence of char-
acteristic clinical features in each cornea (Aldave et al., 2007). After
obtaining informed consent from the parents of each proband and
assent from one of the probands (Case 1), blood was obtained from
each individual and DNA extraction was performed. For each
enrolled individual, genomic DNA was prepared from the periphe-
ral blood leukocytes and buccal epithelial cells using the FlexiGene
DNA and QIAamp DNA Blood Mini Kits (Qiagen, Valencia, CA),
respectively.Fig. 1. MRI images of individuals with PPCD3 and unaffected control individual. Case 1
proband 1 at 10 years of age demonstrate agenesis of the corpus callosum. Case 2. Axial
proband 5 months of age demonstrate thinning of the corpus callosum compared to the
designate the location of the corpus callosum. Case 1 images courtesy of Dr. Elliot Sherr.
Neurological Institute (Colin 27 Average Brain, Stereotaxic Registration Model; Copyright
Institute, McGill University).2.2. PCR ampliﬁcation
Each of the nine coding exons of ZEB1 was ampliﬁed using the
previously described primers and conditions, (Aldave et al., 2007;
Krafchak et al., 2005) with the exception of exon 1, which was
ampliﬁed using custom-designed oligonucleotide primers
(Yellore et al., 2012). Thermal cycling was performed in an iCycler
Thermal Cycler (Bio-Rad, Hercules, CA).
2.3. DNA sequencing
Puriﬁcation of the PCR products and sequencing reactions were
performed using previously described reagents and conditions
(Aldave et al., 2007). Nucleotide sequences, read manually and
with Mutation Surveyor v2.2 (Softgenetics, State College, PA), were
compared to the published ZEB1 RefSeqGene sequence (GenBank
accession number NG_017048.1).
3. Results
3.1. Case 1
A 14 year old girl of mixed European descent, with Italian,
Swedish, Irish, and Dutch ancestry, was diagnosed with congenital
anomalies affecting a number of organ systems, including:
HLA-B27 related spondyloarthropathy and hypermotile joints; a
bicornuate uterus; and agenesis of the corpus callosum and colpo-
cephaly, which were diagnosed on a post-natal CT scan (Fig. 1). The
girl’s parents denied a family history of any corneal disorders or
the other conditions that their daughter demonstrated. An ocular
examination performed at age 15 revealed visual acuities of 20/
20 OD and 20/40 OS. Slit lamp examination revealed bilateral. Axial (top left) and sagittal (bottom left) T1-weighted MRI images performed for
(top middle) and sagittal (bottom middle) T1-weighted MRI images performed for
control images (top and bottom right). Arrows superimposed on the control images
Control images obtained from the McConnell Brain Imaging Center of the Montreal
 1993–2009 Louis Collins, McConnell Brain Imaging Centre, Montreal Neurological
Fig. 2. Case 1. Slit lamp photograph of 14 year old girl demonstrates scattered,
small annular (arrows) and discoid (arrowhead) gray opacities in the corneal
endothelium, with smaller ‘‘vesicles’’ noted within the discoid opacities. Image
courtesy of Dr. Christopher Rapuano.
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endothelium, with smaller ‘‘vesicles’’ noted within the discoid
opacities (Fig. 2). No edema was noted in the corneal epithelium
or stroma, and the remainder of the ocular examination was unre-
markable. Central corneal pachymetry measured 624 lm in the
right eye and 626 lm in the left eye. Specular microscopic imaging
of the central corneal endothelium revealed estimated corneal
endothelial cell densities of 2392 cells/mm2 OD and 2288 cells/
mm2 OS. The girl’s mother and father had normal slit lamp
examinations.
Karyotype, subtelomere FISH and whole genome copy number
variant analyses performed to identify an explanation for the con-
stellation of disorders identiﬁed in the proband were unremark-
able. Screening of the ZEB1 gene in the proband demonstrated a
frameshift mutation in exon 4 (c.449delG; p.(Gly150Alafs36)),
which was not identiﬁed in either of the proband’s parents
(Fig. 3A). Paternity testing conﬁrmed that proband’s father was
indeed the biologic father, indicating that the identiﬁed mutation
was most likely spontaneous.Fig. 3. Pedigrees and results of ZEB1 sequencing in families with a proband affected by
represent affected individuals and open symbols represent unaffected individuals. The p
whom ZEB1 sequencing was performed, the wild type allele (designated by a + symbol) a
wild-type (WT) and mutant (MU) DNA sequences.3.2. Case 2
A 4 year old Caucasian girl with a history of developmental
delay and possible seizures during the ﬁrst few months of life
underwent MRI imaging of the brain at 5 months of life. Thinning
of the corpus callosum was noted, was also seen on subsequent
MRI examinations performed at 23 and 44 months of life (Fig. 1).
The proband’s father also underwent MRI imaging of the brain,
which was unremarkable. Whole genome copy number variant
analysis performed in the proband, her parents and siblings
revealed a 1.79 Mb duplication of 17q12 in the proband (Fig. 3B,
II-3), her father (I-1) and one sibling (II-1), who also had been diag-
nosed with autism. The proband’s mother (I-2) and twin sister (II-
2) were found to have a 1.5 Mb deletion of 1q21.1. The patient was
referred for a complete ocular examination, which revealed cor-
rected distance visual acuity (CDVA) of 20/30 OD and 20/25 OS. Slit
lamp examination demonstrated bilateral, diffusely scattered
endothelial vesicles, without evidence of epithelial or stromal
edema. The remainder of the ocular examination was unremark-
able. However, the central corneal thickness was increased in each
eye, measuring 671 lm in the right eye and 676 lm in the left eye.
Slit lamp examination of the proband’s mother revealed corneal
endothelial changes characteristic of PPCD, which were not identi-
ﬁed in either of the proband’s siblings.
After informed consent was obtained from the proband’s
mother, a saliva sample was obtained from her and each of her
three children as a source of genomic DNA. Screening of the ZEB1
gene in the proband demonstrated a single nucleotide deletion
(c.1913-1914delCA; p.(Ser638Cysfs5)) in exon 7 that was also
present in the proband’s affected mother but absent in her father
and siblings (Fig. 3B).
4. Discussion
Although this represents the initial report of the association of
maldevelopment of the corpus callosum with a corneal dystrophy,
ACC has been reported previously in association with a variety of
inherited retinal disorders. A well-recognized syndrome involvingPPCD and agenesis of the corpus callosum (A – Case 1; B – Case 2). Filled symbols
roband is indicated by a black arrowhead. Below the symbol of each individual in
nd/or the mutant allele is shown. Chromatograms beneath each pedigree depict the
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nantly-inherited X-linked disorder characterized by partial or com-
plete ACC (Fruhman et al., 2012). The pathognomonic ocular
abnormality associated with Aicardi syndrome is chorioretinal
lucinae, which is a condition affecting the retina and is character-
ized by clusters of punched out lesions around the optic disk in
which areas of the choroidal and retinal pigment epithelium have
atrophied (Fruhman et al., 2012; Paul et al., 2007).
The ZEB family of transcription factors is comprised of two
members, ZEB1 and the zinc ﬁnger E-box binding homeobox 2
gene (ZEB2), which regulate various cell functions involved in
development and disease (Postigo et al., 2003). The role of ZEB
proteins in the development of the vertebrate CNS is evident
from the fact that murine ZEB2 protein is present at the neural
crest, while ZEB1 protein is primarily in neural tissues derived
from the neural crest (Takagi et al., 1998). In addition, gene
expression arrays show that ZEB1 and ZEB2 are expressed in sev-
eral vertebrate tissues including the brain (Su et al., 2004; Wu
et al., 2009). However, while ZEB1 protein has been demon-
strated in human corneal endothelium, unpublished RNA micro-
array analysis results obtained from 11 corneal endothelium
samples (donors between 4 and 70 years old) consistently dem-
onstrated the absence of ZEB2 expression (Yellore et al., 2012).
Although ZEB2 is unlikely to play a role in the post-natal endo-
thelium, ZEB2 expression has been distinctly (compared to adult
endothelium) observed in a layer of cuboidal epithelial cells that
line the posterior surface of the early human fetal cornea (Chen
et al., 2013). These early cells are anatomically consistent with,
but morphologically and functionally distinct from, adult corneal
endothelial cells.
Mowat–Wilson Syndrome, which is characterized by presence
of ACC and in at least one case, bilateral microphthalmia, cataract,
and retinal aplasia, is associated with over 100 unique mutations in
ZEB2 (Saunders, Zhao, & Ardinger, 2009). Here, we report two
frameshift mutations in ZEB1 in individuals that have been diag-
nosed with hypoplasia and agenesis of the corpus callosum. Taken
together, the similar functional properties and expression patterns
for ZEB1 and ZEB2 and their apparent association with ACC and
ocular abnormalities suggest that the ZEB family of transcription
factors may play a role in neural and ocular development. How-
ever, we have identiﬁed mutations in ZEB1 in 12 other PPCD3 pro-
bands without developmental delay and other associated clinical
features that characterize ACC. Since many genes and certain envi-
ronmental factors inﬂuence the development of the corpus callo-
sum, the presence of a compensatory mechanism that limits the
deleterious effects of the majority of ZEB1 mutations on neural tis-
sue development may be at play (Paul et al., 2007).
4.1. Conclusion
PPCD3 has previously been described in association with a
number of other ocular and extraocular abnormalities. We report
the ﬁrst association of PPCD3 with a developmental abnormality
of the brain, agenesis of the corpus callosum. Screening of the
ZEB1 gene in two affected individuals demonstrated frameshift
mutations, predicted to result in protein truncation, conﬁrming
the diagnosis of PPCD3. Due to the similar functional properties
and expression patterns for ZEB1 and ZEB 2, and the previous asso-
ciation of mutations within the ZEB2 gene and ACC, we suggest that
the ZEB family of transcription factors may play a role in both neu-
ral and ocular development.
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